CPRX CATALYST PHARMACEUTICALS, INC.

8-K Current Report

Filed: March 18, 2026

Health Care

Pharmaceutical Preparations

CATALYST PHARMACEUTICALS, INC. (CPRX) 8-K current report filed with SEC EDGAR on March 18, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• Trial delay from March 23 to May 18, 2026 on patent validity for FIRDAPSE® listed in Orange Book
• Patents under dispute expire in 2032, 2034, and 2037, critical for protecting FIRDAPSE® revenue

+2 more insights

Other CATALYST PHARMACEUTICALS, INC. 8-K Filings

8-K Mar 19, 2026

8-K Feb 25, 2026

Get deeper insights on CATALYST PHARMACEUTICALS, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.